Atlas Trials

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIIB107 in Healthy Adult Participants

Clinical trial NCT04593121 · COMPLETED

Trial details

NCT number
NCT04593121
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2020-10-30
Primary completion
2024-03-05
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.